Global Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Demand and Key Producers, 2022-2028
This report studies the global Group ACYW135 Meningococcal Polysaccharide Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Group ACYW135 Meningococcal Polysaccharide Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Group ACYW135 Meningococcal Polysaccharide Vaccine that contribute to its increasing demand across many markets.
The global Group ACYW135 Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Group ACYW135 Meningococcal Polysaccharide Vaccine total production and demand, 2017-2028, (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine total production value, 2017-2028, (USD Million)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine domestic production, consumption, key domestic manufacturers and share
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Group ACYW135 Meningococcal Polysaccharide Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Group ACYW135 Meningococcal Polysaccharide Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Group ACYW135 Meningococcal Polysaccharide Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market, By Region:
1. How big is the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
2. What is the demand of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
3. What is the year over year growth of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
4. What is the production and production value of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
5. Who are the key producers in the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Group ACYW135 Meningococcal Polysaccharide Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Group ACYW135 Meningococcal Polysaccharide Vaccine that contribute to its increasing demand across many markets.
The global Group ACYW135 Meningococcal Polysaccharide Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Group ACYW135 Meningococcal Polysaccharide Vaccine total production and demand, 2017-2028, (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine total production value, 2017-2028, (USD Million)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine domestic production, consumption, key domestic manufacturers and share
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Group ACYW135 Meningococcal Polysaccharide Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Group ACYW135 Meningococcal Polysaccharide Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Group ACYW135 Meningococcal Polysaccharide Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Group ACYW135 Meningococcal Polysaccharide Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Class I Vaccines
- Class II Vaccines
- Hospital
- Clinic
- Sanofi-Pasteur
- Walvax Biotechnology
- Chengdu Kanghua Biological Products Co., Ltd
- Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
- Zhejiang Tianyuan Biopharmaceutical Co., Ltd
- Beijing Institute of Biological Products Co., Ltd
- CanSino Biologics AG
- Yuxi Watson Biotechnology Co., Ltd
- Hualan Biovaccine Co., Ltd
- Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
1. How big is the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
2. What is the demand of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
3. What is the year over year growth of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
4. What is the production and production value of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
5. Who are the key producers in the global Group ACYW135 Meningococcal Polysaccharide Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Introduction
1.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Supply & Forecast
1.2.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.2.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Pricing Trends (2017-2028)
1.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region
1.3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2017-2028)
1.3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (2017-2028)
1.3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2017-2028)
1.3.4 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.3.5 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.3.6 China Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.3.7 Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Demand (2017-2028)
2.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption by Region
2.2.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption by Region (2017-2022)
2.2.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.4 China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.5 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.6 Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.7 South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.8 ASEAN Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.9 India Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
3 WORLD GROUP ACYW135 MENINGOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Manufacturer (2017-2022)
3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2017-2022)
3.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021
3.6 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.6.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Region Footprint
3.6.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.6.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Comparison
4.1.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Comparison
4.2.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Comparison
4.3.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Group ACYW135 Meningococcal Polysaccharide Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Group ACYW135 Meningococcal Polysaccharide Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Class I Vaccines
5.2.2 Class II Vaccines
5.3 Market Segment by Type
5.3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Type (2017-2028)
5.3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type (2017-2028)
5.3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Application (2017-2028)
6.3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application (2017-2028)
6.3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sanofi-Pasteur
7.1.1 Sanofi-Pasteur Details
7.1.2 Sanofi-Pasteur Major Business
7.1.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.1.4 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sanofi-Pasteur Recent Developments/Updates
7.1.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
7.2 Walvax Biotechnology
7.2.1 Walvax Biotechnology Details
7.2.2 Walvax Biotechnology Major Business
7.2.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.2.4 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Walvax Biotechnology Recent Developments/Updates
7.2.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.3 Chengdu Kanghua Biological Products Co., Ltd
7.3.1 Chengdu Kanghua Biological Products Co., Ltd Details
7.3.2 Chengdu Kanghua Biological Products Co., Ltd Major Business
7.3.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.3.4 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
7.3.6 Chengdu Kanghua Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
7.4.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Details
7.4.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Major Business
7.4.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.4.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
7.4.6 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
7.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Details
7.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Major Business
7.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
7.5.6 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.6 Beijing Institute of Biological Products Co., Ltd
7.6.1 Beijing Institute of Biological Products Co., Ltd Details
7.6.2 Beijing Institute of Biological Products Co., Ltd Major Business
7.6.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.6.4 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
7.6.6 Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.7 CanSino Biologics AG
7.7.1 CanSino Biologics AG Details
7.7.2 CanSino Biologics AG Major Business
7.7.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.7.4 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 CanSino Biologics AG Recent Developments/Updates
7.7.6 CanSino Biologics AG Competitive Strengths & Weaknesses
7.8 Yuxi Watson Biotechnology Co., Ltd
7.8.1 Yuxi Watson Biotechnology Co., Ltd Details
7.8.2 Yuxi Watson Biotechnology Co., Ltd Major Business
7.8.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.8.4 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
7.8.6 Yuxi Watson Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.9 Hualan Biovaccine Co., Ltd
7.9.1 Hualan Biovaccine Co., Ltd Details
7.9.2 Hualan Biovaccine Co., Ltd Major Business
7.9.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.9.4 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Hualan Biovaccine Co., Ltd Recent Developments/Updates
7.9.6 Hualan Biovaccine Co., Ltd Competitive Strengths & Weaknesses
7.10 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
7.10.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Details
7.10.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Major Business
7.10.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.10.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments/Updates
7.10.6 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Group ACYW135 Meningococcal Polysaccharide Vaccine and Key Manufacturers
8.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Costs
8.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Production Process
8.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Group ACYW135 Meningococcal Polysaccharide Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Distributors
9.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Introduction
1.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Supply & Forecast
1.2.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.2.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Pricing Trends (2017-2028)
1.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region
1.3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2017-2028)
1.3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (2017-2028)
1.3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2017-2028)
1.3.4 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.3.5 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.3.6 China Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.3.7 Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Demand (2017-2028)
2.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption by Region
2.2.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption by Region (2017-2022)
2.2.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.4 China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.5 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.6 Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.7 South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.8 ASEAN Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
2.9 India Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028)
3 WORLD GROUP ACYW135 MENINGOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Manufacturer (2017-2022)
3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2017-2022)
3.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021
3.6 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.6.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Region Footprint
3.6.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.6.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Comparison
4.1.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Comparison
4.2.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Comparison
4.3.1 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Group ACYW135 Meningococcal Polysaccharide Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Group ACYW135 Meningococcal Polysaccharide Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Class I Vaccines
5.2.2 Class II Vaccines
5.3 Market Segment by Type
5.3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Type (2017-2028)
5.3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type (2017-2028)
5.3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Application (2017-2028)
6.3.2 World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application (2017-2028)
6.3.3 World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sanofi-Pasteur
7.1.1 Sanofi-Pasteur Details
7.1.2 Sanofi-Pasteur Major Business
7.1.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.1.4 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sanofi-Pasteur Recent Developments/Updates
7.1.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
7.2 Walvax Biotechnology
7.2.1 Walvax Biotechnology Details
7.2.2 Walvax Biotechnology Major Business
7.2.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.2.4 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Walvax Biotechnology Recent Developments/Updates
7.2.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.3 Chengdu Kanghua Biological Products Co., Ltd
7.3.1 Chengdu Kanghua Biological Products Co., Ltd Details
7.3.2 Chengdu Kanghua Biological Products Co., Ltd Major Business
7.3.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.3.4 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
7.3.6 Chengdu Kanghua Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
7.4.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Details
7.4.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Major Business
7.4.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.4.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
7.4.6 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
7.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Details
7.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Major Business
7.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
7.5.6 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.6 Beijing Institute of Biological Products Co., Ltd
7.6.1 Beijing Institute of Biological Products Co., Ltd Details
7.6.2 Beijing Institute of Biological Products Co., Ltd Major Business
7.6.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.6.4 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
7.6.6 Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.7 CanSino Biologics AG
7.7.1 CanSino Biologics AG Details
7.7.2 CanSino Biologics AG Major Business
7.7.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.7.4 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 CanSino Biologics AG Recent Developments/Updates
7.7.6 CanSino Biologics AG Competitive Strengths & Weaknesses
7.8 Yuxi Watson Biotechnology Co., Ltd
7.8.1 Yuxi Watson Biotechnology Co., Ltd Details
7.8.2 Yuxi Watson Biotechnology Co., Ltd Major Business
7.8.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.8.4 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
7.8.6 Yuxi Watson Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.9 Hualan Biovaccine Co., Ltd
7.9.1 Hualan Biovaccine Co., Ltd Details
7.9.2 Hualan Biovaccine Co., Ltd Major Business
7.9.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.9.4 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Hualan Biovaccine Co., Ltd Recent Developments/Updates
7.9.6 Hualan Biovaccine Co., Ltd Competitive Strengths & Weaknesses
7.10 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
7.10.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Details
7.10.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Major Business
7.10.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
7.10.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments/Updates
7.10.6 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Group ACYW135 Meningococcal Polysaccharide Vaccine and Key Manufacturers
8.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Costs
8.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Production Process
8.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Group ACYW135 Meningococcal Polysaccharide Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Distributors
9.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Region (2017-2022)
Table 9. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Region (2023-2028)
Table 10. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Group ACYW135 Meningococcal Polysaccharide Vaccine Major Market Trends
Table 13. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Group ACYW135 Meningococcal Polysaccharide Vaccine Producers in 2021
Table 18. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Group ACYW135 Meningococcal Polysaccharide Vaccine Producers in 2021
Table 20. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
Table 22. World Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Group ACYW135 Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 24. Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 25. Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 26. Group ACYW135 Meningococcal Polysaccharide Vaccine Competitive Factors
Table 27. Group ACYW135 Meningococcal Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
Table 28. Group ACYW135 Meningococcal Polysaccharide Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi-Pasteur Major Business
Table 63. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 64. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sanofi-Pasteur Recent Developments/Updates
Table 66. Sanofi-Pasteur Competitive Strengths & Weaknesses
Table 67. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 68. Walvax Biotechnology Major Business
Table 69. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 70. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Walvax Biotechnology Recent Developments/Updates
Table 72. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 73. Chengdu Kanghua Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Chengdu Kanghua Biological Products Co., Ltd Major Business
Table 75. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 76. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
Table 78. Chengdu Kanghua Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 79. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Major Business
Table 81. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 82. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 84. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 85. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Major Business
Table 87. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 88. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 90. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 91. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Beijing Institute of Biological Products Co., Ltd Major Business
Table 93. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 94. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 96. Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 97. CanSino Biologics AG Basic Information, Manufacturing Base and Competitors
Table 98. CanSino Biologics AG Major Business
Table 99. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 100. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. CanSino Biologics AG Recent Developments/Updates
Table 102. CanSino Biologics AG Competitive Strengths & Weaknesses
Table 103. Yuxi Watson Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Yuxi Watson Biotechnology Co., Ltd Major Business
Table 105. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 106. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
Table 108. Yuxi Watson Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 109. Hualan Biovaccine Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Hualan Biovaccine Co., Ltd Major Business
Table 111. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 112. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Hualan Biovaccine Co., Ltd Recent Developments/Updates
Table 114. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 115. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Major Business
Table 116. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 117. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 118. Group ACYW135 Meningococcal Polysaccharide Vaccine Raw Material
Table 119. Key Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine Raw Materials
Table 120. Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Distributors
Table 121. Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Customers
Table 1. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Region (2017-2022)
Table 9. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Region (2023-2028)
Table 10. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Group ACYW135 Meningococcal Polysaccharide Vaccine Major Market Trends
Table 13. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Group ACYW135 Meningococcal Polysaccharide Vaccine Producers in 2021
Table 18. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Group ACYW135 Meningococcal Polysaccharide Vaccine Producers in 2021
Table 20. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Company Evaluation Quadrant
Table 22. World Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Group ACYW135 Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 24. Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 25. Group ACYW135 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 26. Group ACYW135 Meningococcal Polysaccharide Vaccine Competitive Factors
Table 27. Group ACYW135 Meningococcal Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
Table 28. Group ACYW135 Meningococcal Polysaccharide Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Group ACYW135 Meningococcal Polysaccharide Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi-Pasteur Major Business
Table 63. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 64. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sanofi-Pasteur Recent Developments/Updates
Table 66. Sanofi-Pasteur Competitive Strengths & Weaknesses
Table 67. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 68. Walvax Biotechnology Major Business
Table 69. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 70. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Walvax Biotechnology Recent Developments/Updates
Table 72. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 73. Chengdu Kanghua Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Chengdu Kanghua Biological Products Co., Ltd Major Business
Table 75. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 76. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
Table 78. Chengdu Kanghua Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 79. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Major Business
Table 81. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 82. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 84. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 85. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Major Business
Table 87. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 88. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 90. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 91. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Beijing Institute of Biological Products Co., Ltd Major Business
Table 93. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 94. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 96. Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 97. CanSino Biologics AG Basic Information, Manufacturing Base and Competitors
Table 98. CanSino Biologics AG Major Business
Table 99. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 100. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. CanSino Biologics AG Recent Developments/Updates
Table 102. CanSino Biologics AG Competitive Strengths & Weaknesses
Table 103. Yuxi Watson Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Yuxi Watson Biotechnology Co., Ltd Major Business
Table 105. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 106. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
Table 108. Yuxi Watson Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 109. Hualan Biovaccine Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Hualan Biovaccine Co., Ltd Major Business
Table 111. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 112. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Hualan Biovaccine Co., Ltd Recent Developments/Updates
Table 114. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 115. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Major Business
Table 116. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product and Services
Table 117. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 118. Group ACYW135 Meningococcal Polysaccharide Vaccine Raw Material
Table 119. Key Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine Raw Materials
Table 120. Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Distributors
Table 121. Group ACYW135 Meningococcal Polysaccharide Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Group ACYW135 Meningococcal Polysaccharide Vaccine Picture
Figure 2. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 5. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 10. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 12. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Group ACYW135 Meningococcal Polysaccharide Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Group ACYW135 Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Group ACYW135 Meningococcal Polysaccharide Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Group ACYW135 Meningococcal Polysaccharide Vaccine Markets in 2021
Figure 26. United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine in United States
Figure 30. Key Producers and Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine in China
Figure 31. Key Producers and Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine in Rest of World
Figure 32. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Type in 2021
Figure 34. Class I Vaccines
Figure 35. Class II Vaccines
Figure 36. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 48. Group ACYW135 Meningococcal Polysaccharide Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Group ACYW135 Meningococcal Polysaccharide Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Group ACYW135 Meningococcal Polysaccharide Vaccine Picture
Figure 2. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 5. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 10. China Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Production (2017-2028) & (K Units)
Figure 12. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Group ACYW135 Meningococcal Polysaccharide Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Group ACYW135 Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Group ACYW135 Meningococcal Polysaccharide Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Group ACYW135 Meningococcal Polysaccharide Vaccine Markets in 2021
Figure 26. United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Group ACYW135 Meningococcal Polysaccharide Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine in United States
Figure 30. Key Producers and Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine in China
Figure 31. Key Producers and Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine in Rest of World
Figure 32. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Type in 2021
Figure 34. Class I Vaccines
Figure 35. Class II Vaccines
Figure 36. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Group ACYW135 Meningococcal Polysaccharide Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 48. Group ACYW135 Meningococcal Polysaccharide Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Group ACYW135 Meningococcal Polysaccharide Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
